CED Member Metabolon Inc. announced today that it has acquired Lipomics Technologies, Inc., a company based in Sacramento, California. Financial details were not disclosed.
Lipomics will maintain its laboratory facilities in its Scaramento headquarters. Metabolon's headquarters and laboratories will remain in Research Triangle Park.
The transaction combines Metabolon's technology platform with Lipomics' lipids profiling technologies.
"By combining our two companies, we have more than 140 employees and 450 clients," said John Ryals, Ph.D., chief executive officer of Metabolon, in a statement.
Steven M. Watkins, Ph.D., the founder of Lipomics, will join Metabolon's executive team as chief technology officer.